Wilson Sonsini Goodrich & Rosati advised Regor Therapeutics on the deal.Eli Lilly and Company and Regor Therapeutics Group entered into a multi-year research collaboration and licensing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
